Risk of work-related injury in workers with obstructive sleep apnea: A systematic review and meta-analysis.
Kun-Ta Chou, Yu-Lun Tsai, Wan-Yu Yeh...
https://pubmed.ncbi.nlm.nih.gov/34384138Actively Recruiting
Led by Centre Hospitalier Régional d'Orléans · Updated on 2025-12-30
58
Participants Needed
1
Research Sites
13 weeks
Total Duration
Obstructive sleep apnea (OSA) is a sleep disorder marked by partial or complete pauses in breathing during sleep, often caused by a narrowing of the upper airway and muscle weakness. This condition leads to excessive tiredness and daytime sleepiness, affecting patients' quality of life. While the standard treatment, continuous positive airway pressure (CPAP), improves symptoms, its long-term use compliance is limited, highlighting the need for additional therapies. Researchers are exploring inspiratory muscle training (IMT), which strengthens muscles like the diaphragm to help keep airways open, as a potential supportive treatment for OSA. The study compares two groups: one receiving inspiratory muscle training along with CPAP and one receiving CPAP alone. IMT sessions last 12 to 20 minutes and include three cycles of 30 breaths against resistance using a valve device, with breaks between cycles. Participants will start CPAP treatment and undergo assessments including the Epworth Sleepiness Scale and maximum inspiratory pressure measurement. Follow-up includes a six-week phone check and a visit at 12 weeks to review CPAP use and repeat assessments. Participants will be evaluated at diagnosis and during follow-up visits with questionnaires and pressure measurements to monitor daytime sleepiness and respiratory muscle strength. Researchers measure changes in daytime sleepiness after 12 weeks as the main outcome. The study involves regular monitoring through consultations and phone calls over 12 weeks, with safety and treatment adherence tracked to understand the impact of adding inspiratory muscle training to standard CPAP therapy.
CONDITIONS
Effect of Inspiratory Muscle Training in Obstructive Sleep Apnea Syndrome.
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during consultation to diagnose obstructive sleep disorder with the pulmonologist following polysomnography
Duration - 12 weeks
Participants receive inspiratory muscle training alongside continuous positive airway pressure (CPAP) treatment to reduce daytime sleepiness caused by obstructive sleep apnea.
6-week telephone follow-up and a follow-up visit at 12 weeks after CPAP introduction
Total: 1 location
1
Chu Orleans
Orléans, France
Actively Recruiting
A
Aurelie DESPUJOLS, Msc
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kun-Ta Chou, Yu-Lun Tsai, Wan-Yu Yeh...
https://pubmed.ncbi.nlm.nih.gov/34384138AbdelKebir Sabil, Remi Bignard, Chloé Gervès-Pinquié...
https://pubmed.ncbi.nlm.nih.gov/34675722Jiale Peng, Yuling Yuan, Yuanhui Zhao...
https://pubmed.ncbi.nlm.nih.gov/36078558A Abdelghani, S Slama, A Hayouni...
https://pubmed.ncbi.nlm.nih.gov/19524803L M de Azeredo, L C de Souza, B L S Guimarães...
https://pubmed.ncbi.nlm.nih.gov/36197415Danny J Eckert, David P White, Amy S Jordan...
https://pubmed.ncbi.nlm.nih.gov/23721582